-
1
-
-
19944431003
-
-
Lindsley, C. W.; Zhao, Z.; Leister, W. H.; Robinson, R. G.; Barnett, S. F.; Defeo-Jones, D.; Jones, R. E.; Hartman, G. D.; Huff, J. R.; Huber, H. E.; Duggan, M. E. Bioorg. Med. Chem. Lett. 2005, 15, 761.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, pp. 761
-
-
Lindsley, C.W.1
Zhao, Z.2
Leister, W.H.3
Robinson, R.G.4
Barnett, S.F.5
Defeo-Jones, D.6
Jones, R.E.7
Hartman, G.D.8
Huff, J.R.9
Huber, H.E.10
Duggan, M.E.11
-
2
-
-
0031011007
-
-
Loriga, M.; Piras, S.; Sanna, P.; Paglietti, G. Farmaco 1997, 52, 157.
-
(1997)
Farmaco
, vol.52
, pp. 157
-
-
Loriga, M.1
Piras, S.2
Sanna, P.3
Paglietti, G.4
-
3
-
-
0037028002
-
-
Seitz, L. E.; Suling, W. J.; Reynolds, R. C. J. Med. Chem. 2002, 45, 5604.
-
(2002)
J. Med. Chem
, vol.45
, pp. 5604
-
-
Seitz, L.E.1
Suling, W.J.2
Reynolds, R.C.3
-
4
-
-
12444339774
-
-
He, W.; Meyers, M. R.; Hanney, B.; Spada, A.; Blider, G.; Galzeinski, H.; Amin, D.; Needle, S.; Page, K.; Jayyosi, Z.; Perrone, H. Bioorg. Med. Chem. Lett. 2003, 13, 3097.
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, pp. 3097
-
-
He, W.1
Meyers, M.R.2
Hanney, B.3
Spada, A.4
Blider, G.5
Galzeinski, H.6
Amin, D.7
Needle, S.8
Page, K.9
Jayyosi, Z.10
Perrone, H.11
-
5
-
-
0346729859
-
-
Kim, Y. B.; Kim, Y. H.; Park, J. Y.; Kim, S. K. Bioorg. Med. Chem. Lett. 2004, 14, 541.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 541
-
-
Kim, Y.B.1
Kim, Y.H.2
Park, J.Y.3
Kim, S.K.4
-
7
-
-
0034143252
-
-
Katoh, A.; Yoshida, T.; Ohkanda, J. Heterocycles 2000, 52, 911.
-
(2000)
Heterocycles
, vol.52
, pp. 911
-
-
Katoh, A.1
Yoshida, T.2
Ohkanda, J.3
-
8
-
-
0034842923
-
-
Dailey, S.; Feast, J. W.; Peace, R. J.; Sage, I. C.; Till, S.; Wood, E. L. J. Mater. Chem. 2001, 11, 2238.
-
(2001)
J. Mater. Chem
, vol.11
, pp. 2238
-
-
Dailey, S.1
Feast, J.W.2
Peace, R.J.3
Sage, I.C.4
Till, S.5
Wood, E.L.6
-
9
-
-
0030213929
-
-
O'Brien, D.; Weaver, M. S.; Lidzey, D. G.; Bradley, D. D. C. Appl. Phys. Lett. 1996, 69, 881.
-
(1996)
Appl. Phys. Lett
, vol.69
, pp. 881
-
-
O'Brien, D.1
Weaver, M.S.2
Lidzey, D.G.3
Bradley, D.D.C.4
-
10
-
-
0032840116
-
-
Bailly, C.; Echepare, S.; Gago, F.; Waring, M. Anti-Cancer Drug Des. 1999, 14, 291.
-
(1999)
Anti-Cancer Drug Des
, vol.14
, pp. 291
-
-
Bailly, C.1
Echepare, S.2
Gago, F.3
Waring, M.4
-
11
-
-
0141567587
-
-
Raw, S. A.; Wilfred, C. D.; Taylor, R. J. K. Chem. Commun. 2003, 18, 2286.
-
(2003)
Chem. Commun
, vol.18
, pp. 2286
-
-
Raw, S.A.1
Wilfred, C.D.2
Taylor, R.J.K.3
-
12
-
-
0003989782
-
-
2nd ed, Wiley and Sons: New York
-
Gilchrist, T. L. Heterocyclic Chemistry, 2nd ed.; Wiley and Sons: New York, 1992, 272-276.
-
(1992)
Heterocyclic Chemistry
, pp. 272-276
-
-
Gilchrist, T.L.1
-
13
-
-
33845359458
-
-
Taylor, E. C.; Maryanoff, C. A.; Skotnickilc, J. S. J. Org. Chem. 1980, 45, 2513.
-
(1980)
J. Org. Chem
, vol.45
, pp. 2513
-
-
Taylor, E.C.1
Maryanoff, C.A.2
Skotnickilc, J.S.3
-
17
-
-
67651226621
-
-
General Procedure for the Synthesis of Compounds 4 To a suspension of 3 (2 mmol)18 in CH2Cl2 (10 mL) was added of malonyl dichloride (0.29 g, 2.1 mmol) at r.t. The reaction mixture was then stirred for 15 min. The formed precipitate was filtered off and washed with CH2Cl2 to afford the pure product. Compound 4a: pale yellow powder; mp 300-304°C (dec, yield 0.56 g (98, IR (KBr, νmax, 3450, 1729, 1693, 1655, 1490, 1418, 1365, 1306, 1258, 1106, 757 cm-1. 1H NMR (500 MHz, CDCl3, δ, 3.74 (3 H, s, OMe, 6.08 (1 H, s, CH, 7.12 (1 H, d, 3J, 7.8 Hz, CH, 7.20 (1 H, t, 3J, 7.9 Hz, CH, 7.30 (1 H, t, 3J, 8.0 Hz, CH, 9.19 (1 H, d, 3J, 7.8 Hz, CH, 11.76 (1 H, s, OH, 11.84 (1 H, s, NH) ppm. 13C NMR (125.7 MHz, CDCl3, δ, 52.6 (OMe, 102.9 (CH, 112.4 C
-
5 (286.24): C, 58.75; H, 3.52; N, 9.79. Found: C, 58.60; H, 3.44; N, 9.65.
-
-
-
-
18
-
-
67651218362
-
-
Compound 4d: pale yellow powder; mp 298-300°C (dec, yield 0.55 g (97, IR (KBr) νmax, 3505, 1764, 1721, 1661, 1618, 1499, 1408, 1333, 1304, 1294, 1106, 759 cm-1. 1H NMR (500 MHz, CDCl3, δ, 3.79 (3 H, s, OMe, 6.12 (1 H, s, CH, 7.27 (1 H, t, 3J, 7.0 Hz, CH, 7.30 (1 H, d, 3J, 7.9 Hz, CH, 7.33 (1 H, t, 3J, 8.0 Hz, CH, 9.18 (1 H, d, 3J, 8.6 Hz, CH, 12.01 (1 H, s, OH) ppm.13C NMR (125.7 MHz, CDCl3, δ, 52.5 (OMe, 104.1 (CH, 114.8 (C, 116.8 (CH, 120.6 (CH, 123.1 (C, 124.3 (CH, 127.0 (CH, 127.9 (C, 141.1 (C, 154.2 (COH, 161.4 (CO, 161.5 (CO, 164.1 (CO2) ppm. Anal. Calcd, ) for C14H9NO6 287.22, C, 58.54; H, 3.16; N, 4.88. Found: C, 58.60; H, 3.14; N, 4.85
-
6 (287.22): C, 58.54; H, 3.16; N, 4.88. Found: C, 58.60; H, 3.14; N, 4.85.
-
-
-
-
19
-
-
67651246398
-
-
Compound 4g: yellow powder; mp 298-301°C (dec, yield 0.58 g (98, IR (KBr) νmax, 3440, 1764, 1722, 1665, 1621, 1455, 1324, 1286, 1250, 1107, 765 cm-1. 1H NMR (500 MHz, CDCl 3, δ, 2.32 (3 H, s, Me, 3.78 (3 H, s, OMe, 6.10 (1 H, s, CH, 7.15 (1 H, d, 3J, 8.3 Hz, CH, 7.19 (1 H, d, 3J, 8.3 Hz, 9.03 (1 H, s, CH, 11.99 (1 H, s, OH) ppm. 13C NMR (125.7 MHz, CDCl3, δ, 20.9 (Me, 52.4 (OMe, 104.1 (CH, 114.8 (C, 116.5 (CH, 120.7 (CH, 122.6 (C, 127.4 (CH, 127.9 (C, 133.5 (C, 139.0 (C, 154.3 (C-OH, 161.3 (CO, 161.4 (CO, 164.1 (CO2) ppm. Anal. Calcd, ) for C15H11NO 6 301.25, C, 59.81; H, 3.68; N, 4.65. Found: C, 59.80; H, 3.65; N, 4.65. All other novel compounds isolated possessed spectroscopic and analytical data in keeping with their proposed structures
-
6 (301.25): C, 59.81; H, 3.68; N, 4.65. Found: C, 59.80; H, 3.65; N, 4.65. All other novel compounds isolated possessed spectroscopic and analytical data in keeping with their proposed structures.
-
-
-
-
20
-
-
33845367818
-
-
Yavari, I.; Mirzaie, A.; Moradi, L. Helv. Chim. Acta 2006, 89, 2825.
-
(2006)
Helv. Chim. Acta
, vol.89
, pp. 2825
-
-
Yavari, I.1
Mirzaie, A.2
Moradi, L.3
-
21
-
-
0030494642
-
-
Yavari, I.; Shaabani, A.; Soliemani, H.; Nourmohammadian, F.; Bijanzadeh, H. Magn. Reson. Chem. 1996, 34, 1003.
-
(1996)
Magn. Reson. Chem
, vol.34
, pp. 1003
-
-
Yavari, I.1
Shaabani, A.2
Soliemani, H.3
Nourmohammadian, F.4
Bijanzadeh, H.5
-
22
-
-
33751125546
-
-
Kappe, T.; Linnau, Y.; Stadlbauer, W. Monatsh. Chem. 1977, 108, 103.
-
(1977)
Monatsh. Chem
, vol.108
, pp. 103
-
-
Kappe, T.1
Linnau, Y.2
Stadlbauer, W.3
|